Runx1 alleviates osteoarthritis progression in aging mice

Area of Science:

• Biomedical Science
• Orthopedics
• Molecular Biology

Background:

• Osteoarthritis (OA) is a leading cause of chronic disability in aging populations, characterized by joint pain and reduced mobility.
• Current treatments for OA are limited, with no definitive cure available.
• Runt-related transcription factor 1 (Runx1) has demonstrated a protective role in osteoarthritis development by promoting chondrogenesis.

Purpose of the Study:

• To investigate the therapeutic potential of intra-articular adeno-associated virus/Runx1 (AAV/Runx1) injection in aging mouse models of osteoarthritis.
• To evaluate the effect of Runx1 on articular cartilage integrity and pathological markers in OA.

Main Methods:

• Osteoarthritis was induced in aging mice using anterior cruciate ligament transection (ACLT).
• Intra-articular injections of AAV/Runx1 were administered to the OA mouse models.
• Articular cartilage integrity, proteoglycan content, and relevant pathological/physiological markers were analyzed.

Main Results:

• The AAV/Runx1-treated group exhibited better articular cartilage integrity and higher proteoglycan retention compared to the untreated OA group.
• Markers associated with pathological cartilage changes were downregulated in the AAV/Runx1 group.
• Markers indicative of physiological cartilage changes were upregulated following AAV/Runx1 administration.

Conclusions:

• Runx1 delivery via AAV/Runx1 injection appears to impede osteoarthritis progression in the knee joints of aging mice.
• Runx1 may possess a protective role in OA pathogenesis.
• Runx1 represents a potential therapeutic target for osteoarthritis treatment in aging patients.